Target intelligence / Profile preview

Retinoic acid receptor-related orphan receptor alpha (RORα) (RORα)

Target
RORα
Molecular classification
Nuclear receptor, Transcription factor
01

Overview

Retinoic acid receptor-related orphan receptor alpha (RORα) is a member of the nuclear receptor superfamily that functions as a ligand-dependent transcription factor. It plays a critical role in regulating the molecular clock, particularly through the transcriptional activation of BMAL1, thereby influencing circadian rhythms (UniProt P35398). Beyond its role in the biological clock, RORα is essential for cerebellar development, lipid metabolism, and the regulation of inflammatory responses, specifically in the differentiation of Th17 cells (PubMed 20610536). While historically identified as a potential nuclear receptor for melatonin (RZRα), its primary endogenous ligands are now considered to be oxysterols and cholesterol derivatives (PubMed 21666606). RORα is implicated in various pathologies, including metabolic syndrome, autoimmune disorders, and certain cancers, making it a significant therapeutic target. Pharmacological modulation via synthetic agonists or inverse agonists aims to treat conditions like type 2 diabetes and neuroinflammation by fine-tuning the expression of genes involved in glucose production and cytokine release (PubMed 21170040).

Other names
RORARZR-alphaNR1F1Retinoid-related orphan receptor alphaNuclear melatonin receptor
02

Mechanism of action

Ligand-dependent transcriptional regulation of target genes through binding to ROR response elements (ROREs) in DNA.

03

Biological functions

Circadian rhythm regulationLipid metabolismImmune responseCerebellar developmentGlucose homeostasis
04

Disease associations

Autoimmune diseaseMetabolic syndromeType 2 diabetesCancerNeurodegenerative diseaseSleep disorder
05

Safety considerations

Disruption of circadian rhythmsPotential for metabolic dysregulationOff-target effects on immune homeostasis
06

Interacting drugs

Melatonin

5 more in the full profile.

07

Biomarkers

BMAL1 expressionIL-17 levelsTh17 cell count

Beyond the preview

Go deeper on Retinoic acid receptor-related orphan receptor alpha (RORα) (RORα).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoic acid receptor-related orphan receptor alpha (RORα) (RORα).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call